Doctor Zi-Wen Zhao
Union Hospital, Fujian Medical University,, Fuzhou (China)
Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study
Event: ESC Congress 2019
Topic: Biomarkers
Session: Acute Coronary Syndromes: Biomarkers
ESC 365 is supported by
